MICROVASCULAR INFLAMMATION - MVI IN KINDEY TRANSPLANT RECIPIENTS

Clinical trials for MICROVASCULAR INFLAMMATION - MVI IN KINDEY TRANSPLANT RECIPIENTS explained in plain language.

Never miss a new study

Get alerted when new MICROVASCULAR INFLAMMATION - MVI IN KINDEY TRANSPLANT RECIPIENTS trials appear

Sign up with your email to follow new studies for MICROVASCULAR INFLAMMATION - MVI IN KINDEY TRANSPLANT RECIPIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug tested to save transplanted kidneys from silent attack

Disease control Ongoing

This study is testing whether a drug called daratumumab can reduce harmful inflammation in the blood vessels of transplanted kidneys, a condition that can lead to organ failure. Kidney transplant recipients with this specific type of inflammation will receive either the drug or s…

Matched conditions: MICROVASCULAR INFLAMMATION - MVI IN KINDEY TRANSPLANT RECIPIENTS

Phase: PHASE4 • Sponsor: University Hospital, Martin • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

MICROVASCULAR INFLAMMATION - MVI IN KINDEY TRANSPLANT RECIPIENTS

Get alerted when new MICROVASCULAR INFLAMMATION - MVI IN KINDEY TRANSPLANT RECIPIENTS trials appear

New drug tested to save transplanted kidneys from silent attack